health
Study finds Ethiopia lacks data to guide MenAfriVac policy
A medRxiv preprint finds that Ethiopia’s current meningococcal surveillance cannot determine whether protection from the MenAfriVac campaign is waning or which non-A serogroups are circulating. An indirect model estimates population protection fell from 85% in 2015 to 24% in 2024.